SSRI-reduced platelet reactivity in non-responding patients with life-long Recurrent Depressive Disorder: Detection and involved mechanisms
Journal
Thrombosis research
Date Issued
2018-05
Author(s)
Aleksovski, Boris
Neceva, Violeta
Vujović, Viktorija
Spasovska, Anastazija
Aleksovski, Vasko
DOI
10.1016/j.thromres.2018.03.006
Abstract
Adverse effects with bleeding disorders are often associated with the administration of SSRI in depression, although the exact mechanisms remain contradicting. This study is aimed at detecting and exploring the mechanisms of SSRI-induced changes in platelet reactivity in non-responding patients with Recurrent Depressive Disorder (RDD) and life-long exposure to antidepressants.
